nodes	percent_of_prediction	percent_of_DWPC	metapath
Nalbuphine—Naloxone—TLR4—chronic obstructive pulmonary disease	0.0199	0.745	CrCbGaD
Nalbuphine—Cramp muscle—Formoterol—chronic obstructive pulmonary disease	0.00586	0.00602	CcSEcCtD
Nalbuphine—Cramp muscle—Montelukast—chronic obstructive pulmonary disease	0.00574	0.0059	CcSEcCtD
Nalbuphine—Asthma—Formoterol—chronic obstructive pulmonary disease	0.00562	0.00578	CcSEcCtD
Nalbuphine—Asthma—Arformoterol—chronic obstructive pulmonary disease	0.00562	0.00578	CcSEcCtD
Nalbuphine—Dyspepsia—Roflumilast—chronic obstructive pulmonary disease	0.00555	0.0057	CcSEcCtD
Nalbuphine—Cramp muscle—Salbutamol—chronic obstructive pulmonary disease	0.00553	0.00568	CcSEcCtD
Nalbuphine—Bronchospasm—Arformoterol—chronic obstructive pulmonary disease	0.00553	0.00568	CcSEcCtD
Nalbuphine—Bronchospasm—Formoterol—chronic obstructive pulmonary disease	0.00553	0.00568	CcSEcCtD
Nalbuphine—Asthma—Montelukast—chronic obstructive pulmonary disease	0.00551	0.00566	CcSEcCtD
Nalbuphine—Flushing—Aminophylline—chronic obstructive pulmonary disease	0.00549	0.00564	CcSEcCtD
Nalbuphine—Asthma—Salbutamol—chronic obstructive pulmonary disease	0.00531	0.00546	CcSEcCtD
Nalbuphine—Bronchospasm—Salbutamol—chronic obstructive pulmonary disease	0.00522	0.00537	CcSEcCtD
Nalbuphine—Feeling abnormal—Roflumilast—chronic obstructive pulmonary disease	0.00519	0.00533	CcSEcCtD
Nalbuphine—Sweating increased—Salbutamol—chronic obstructive pulmonary disease	0.00517	0.00531	CcSEcCtD
Nalbuphine—Gastrointestinal pain—Roflumilast—chronic obstructive pulmonary disease	0.00515	0.00529	CcSEcCtD
Nalbuphine—Tension—Aminophylline—chronic obstructive pulmonary disease	0.00505	0.00519	CcSEcCtD
Nalbuphine—Urticaria—Roflumilast—chronic obstructive pulmonary disease	0.00501	0.00514	CcSEcCtD
Nalbuphine—Nervousness—Aminophylline—chronic obstructive pulmonary disease	0.005	0.00514	CcSEcCtD
Nalbuphine—Delusion—Prednisone—chronic obstructive pulmonary disease	0.00498	0.00512	CcSEcCtD
Nalbuphine—Abdominal pain—Roflumilast—chronic obstructive pulmonary disease	0.00498	0.00512	CcSEcCtD
Nalbuphine—Tremor—Aminophylline—chronic obstructive pulmonary disease	0.00482	0.00496	CcSEcCtD
Nalbuphine—Agitation—Aminophylline—chronic obstructive pulmonary disease	0.00473	0.00486	CcSEcCtD
Nalbuphine—Hypersensitivity—Roflumilast—chronic obstructive pulmonary disease	0.00464	0.00477	CcSEcCtD
Nalbuphine—Vision blurred—Tiotropium—chronic obstructive pulmonary disease	0.00458	0.0047	CcSEcCtD
Nalbuphine—Asthenia—Roflumilast—chronic obstructive pulmonary disease	0.00452	0.00464	CcSEcCtD
Nalbuphine—Convulsion—Aminophylline—chronic obstructive pulmonary disease	0.00446	0.00458	CcSEcCtD
Nalbuphine—Hallucination—Montelukast—chronic obstructive pulmonary disease	0.00439	0.00451	CcSEcCtD
Nalbuphine—Hypoaesthesia—Montelukast—chronic obstructive pulmonary disease	0.00439	0.00451	CcSEcCtD
Nalbuphine—Anxiety—Aminophylline—chronic obstructive pulmonary disease	0.00437	0.00449	CcSEcCtD
Nalbuphine—Syncope—Tiotropium—chronic obstructive pulmonary disease	0.00435	0.00447	CcSEcCtD
Nalbuphine—Buprenorphine—CYP1A2—chronic obstructive pulmonary disease	0.00433	0.162	CrCbGaD
Nalbuphine—Pulmonary oedema—Prednisolone—chronic obstructive pulmonary disease	0.00432	0.00444	CcSEcCtD
Nalbuphine—Loss of consciousness—Tiotropium—chronic obstructive pulmonary disease	0.00427	0.00438	CcSEcCtD
Nalbuphine—Hypoaesthesia—Salbutamol—chronic obstructive pulmonary disease	0.00423	0.00434	CcSEcCtD
Nalbuphine—Hypertension—Tiotropium—chronic obstructive pulmonary disease	0.00419	0.00431	CcSEcCtD
Nalbuphine—Euphoric mood—Prednisolone—chronic obstructive pulmonary disease	0.00417	0.00428	CcSEcCtD
Nalbuphine—Dizziness—Roflumilast—chronic obstructive pulmonary disease	0.00417	0.00428	CcSEcCtD
Nalbuphine—Shock—Aminophylline—chronic obstructive pulmonary disease	0.00413	0.00425	CcSEcCtD
Nalbuphine—Tachycardia—Aminophylline—chronic obstructive pulmonary disease	0.0041	0.00421	CcSEcCtD
Nalbuphine—Dry mouth—Tiotropium—chronic obstructive pulmonary disease	0.00404	0.00415	CcSEcCtD
Nalbuphine—Vomiting—Roflumilast—chronic obstructive pulmonary disease	0.00401	0.00412	CcSEcCtD
Nalbuphine—Rash—Roflumilast—chronic obstructive pulmonary disease	0.00397	0.00408	CcSEcCtD
Nalbuphine—Dermatitis—Roflumilast—chronic obstructive pulmonary disease	0.00397	0.00408	CcSEcCtD
Nalbuphine—Oedema—Tiotropium—chronic obstructive pulmonary disease	0.00396	0.00407	CcSEcCtD
Nalbuphine—Headache—Roflumilast—chronic obstructive pulmonary disease	0.00395	0.00406	CcSEcCtD
Nalbuphine—Flushing—Salbutamol—chronic obstructive pulmonary disease	0.00394	0.00405	CcSEcCtD
Nalbuphine—Hypotension—Aminophylline—chronic obstructive pulmonary disease	0.00393	0.00403	CcSEcCtD
Nalbuphine—Shock—Tiotropium—chronic obstructive pulmonary disease	0.0039	0.00401	CcSEcCtD
Nalbuphine—Tachycardia—Tiotropium—chronic obstructive pulmonary disease	0.00387	0.00397	CcSEcCtD
Nalbuphine—Tension—Arformoterol—chronic obstructive pulmonary disease	0.00384	0.00395	CcSEcCtD
Nalbuphine—Tension—Formoterol—chronic obstructive pulmonary disease	0.00384	0.00395	CcSEcCtD
Nalbuphine—Dysgeusia—Formoterol—chronic obstructive pulmonary disease	0.00384	0.00394	CcSEcCtD
Nalbuphine—Dysgeusia—Arformoterol—chronic obstructive pulmonary disease	0.00384	0.00394	CcSEcCtD
Nalbuphine—Nervousness—Formoterol—chronic obstructive pulmonary disease	0.00381	0.00391	CcSEcCtD
Nalbuphine—Nervousness—Arformoterol—chronic obstructive pulmonary disease	0.00381	0.00391	CcSEcCtD
Nalbuphine—Muscle spasms—Formoterol—chronic obstructive pulmonary disease	0.00377	0.00387	CcSEcCtD
Nalbuphine—Muscle spasms—Arformoterol—chronic obstructive pulmonary disease	0.00377	0.00387	CcSEcCtD
Nalbuphine—Nausea—Roflumilast—chronic obstructive pulmonary disease	0.00374	0.00384	CcSEcCtD
Nalbuphine—Dyspepsia—Aminophylline—chronic obstructive pulmonary disease	0.0037	0.0038	CcSEcCtD
Nalbuphine—Muscle spasms—Montelukast—chronic obstructive pulmonary disease	0.00369	0.00379	CcSEcCtD
Nalbuphine—Tremor—Arformoterol—chronic obstructive pulmonary disease	0.00367	0.00377	CcSEcCtD
Nalbuphine—Tremor—Formoterol—chronic obstructive pulmonary disease	0.00367	0.00377	CcSEcCtD
Nalbuphine—Tension—Salbutamol—chronic obstructive pulmonary disease	0.00363	0.00373	CcSEcCtD
Nalbuphine—Dysgeusia—Salbutamol—chronic obstructive pulmonary disease	0.00362	0.00372	CcSEcCtD
Nalbuphine—Agitation—Formoterol—chronic obstructive pulmonary disease	0.0036	0.0037	CcSEcCtD
Nalbuphine—Agitation—Arformoterol—chronic obstructive pulmonary disease	0.0036	0.0037	CcSEcCtD
Nalbuphine—Tremor—Montelukast—chronic obstructive pulmonary disease	0.0036	0.00369	CcSEcCtD
Nalbuphine—Nervousness—Salbutamol—chronic obstructive pulmonary disease	0.00359	0.00369	CcSEcCtD
Nalbuphine—Paraesthesia—Tiotropium—chronic obstructive pulmonary disease	0.00356	0.00366	CcSEcCtD
Nalbuphine—Muscle spasms—Salbutamol—chronic obstructive pulmonary disease	0.00356	0.00365	CcSEcCtD
Nalbuphine—Agitation—Montelukast—chronic obstructive pulmonary disease	0.00353	0.00362	CcSEcCtD
Nalbuphine—Dyspepsia—Tiotropium—chronic obstructive pulmonary disease	0.00349	0.00358	CcSEcCtD
Nalbuphine—Tremor—Salbutamol—chronic obstructive pulmonary disease	0.00347	0.00356	CcSEcCtD
Nalbuphine—Gastrointestinal pain—Aminophylline—chronic obstructive pulmonary disease	0.00344	0.00353	CcSEcCtD
Nalbuphine—Agitation—Salbutamol—chronic obstructive pulmonary disease	0.0034	0.00349	CcSEcCtD
Nalbuphine—Hypertension—Formoterol—chronic obstructive pulmonary disease	0.00338	0.00348	CcSEcCtD
Nalbuphine—Hypertension—Arformoterol—chronic obstructive pulmonary disease	0.00338	0.00348	CcSEcCtD
Nalbuphine—Cardiac arrest—Prednisolone—chronic obstructive pulmonary disease	0.00335	0.00344	CcSEcCtD
Nalbuphine—Urticaria—Aminophylline—chronic obstructive pulmonary disease	0.00334	0.00343	CcSEcCtD
Nalbuphine—Convulsion—Montelukast—chronic obstructive pulmonary disease	0.00333	0.00342	CcSEcCtD
Nalbuphine—Anxiety—Formoterol—chronic obstructive pulmonary disease	0.00332	0.00342	CcSEcCtD
Nalbuphine—Anxiety—Arformoterol—chronic obstructive pulmonary disease	0.00332	0.00342	CcSEcCtD
Nalbuphine—Vertigo—Salbutamol—chronic obstructive pulmonary disease	0.00332	0.00341	CcSEcCtD
Nalbuphine—Abdominal pain—Aminophylline—chronic obstructive pulmonary disease	0.00332	0.00341	CcSEcCtD
Nalbuphine—Body temperature increased—Aminophylline—chronic obstructive pulmonary disease	0.00332	0.00341	CcSEcCtD
Nalbuphine—Syncope—Salbutamol—chronic obstructive pulmonary disease	0.00332	0.00341	CcSEcCtD
Nalbuphine—Dry mouth—Arformoterol—chronic obstructive pulmonary disease	0.00326	0.00335	CcSEcCtD
Nalbuphine—Dry mouth—Formoterol—chronic obstructive pulmonary disease	0.00326	0.00335	CcSEcCtD
Nalbuphine—Anxiety—Montelukast—chronic obstructive pulmonary disease	0.00326	0.00335	CcSEcCtD
Nalbuphine—Loss of consciousness—Salbutamol—chronic obstructive pulmonary disease	0.00325	0.00334	CcSEcCtD
Nalbuphine—Gastrointestinal pain—Tiotropium—chronic obstructive pulmonary disease	0.00324	0.00333	CcSEcCtD
Nalbuphine—Oedema—Arformoterol—chronic obstructive pulmonary disease	0.0032	0.00329	CcSEcCtD
Nalbuphine—Oedema—Formoterol—chronic obstructive pulmonary disease	0.0032	0.00329	CcSEcCtD
Nalbuphine—Hypertension—Salbutamol—chronic obstructive pulmonary disease	0.00319	0.00328	CcSEcCtD
Nalbuphine—Urticaria—Tiotropium—chronic obstructive pulmonary disease	0.00315	0.00323	CcSEcCtD
Nalbuphine—Pulmonary oedema—Prednisone—chronic obstructive pulmonary disease	0.00314	0.00323	CcSEcCtD
Nalbuphine—Anxiety—Salbutamol—chronic obstructive pulmonary disease	0.00314	0.00322	CcSEcCtD
Nalbuphine—Abdominal pain—Tiotropium—chronic obstructive pulmonary disease	0.00313	0.00322	CcSEcCtD
Nalbuphine—Oedema—Montelukast—chronic obstructive pulmonary disease	0.00313	0.00322	CcSEcCtD
Nalbuphine—Tachycardia—Formoterol—chronic obstructive pulmonary disease	0.00312	0.00321	CcSEcCtD
Nalbuphine—Tachycardia—Arformoterol—chronic obstructive pulmonary disease	0.00312	0.00321	CcSEcCtD
Nalbuphine—Hypersensitivity—Aminophylline—chronic obstructive pulmonary disease	0.0031	0.00318	CcSEcCtD
Nalbuphine—Dry mouth—Salbutamol—chronic obstructive pulmonary disease	0.00308	0.00316	CcSEcCtD
Nalbuphine—Euphoric mood—Prednisone—chronic obstructive pulmonary disease	0.00303	0.00311	CcSEcCtD
Nalbuphine—Oedema—Salbutamol—chronic obstructive pulmonary disease	0.00302	0.0031	CcSEcCtD
Nalbuphine—Hypotension—Arformoterol—chronic obstructive pulmonary disease	0.00299	0.00307	CcSEcCtD
Nalbuphine—Hypotension—Formoterol—chronic obstructive pulmonary disease	0.00299	0.00307	CcSEcCtD
Nalbuphine—Pruritus—Aminophylline—chronic obstructive pulmonary disease	0.00297	0.00305	CcSEcCtD
Nalbuphine—Shock—Salbutamol—chronic obstructive pulmonary disease	0.00297	0.00305	CcSEcCtD
Nalbuphine—Sweating increased—Prednisolone—chronic obstructive pulmonary disease	0.00297	0.00305	CcSEcCtD
Nalbuphine—Tachycardia—Salbutamol—chronic obstructive pulmonary disease	0.00295	0.00303	CcSEcCtD
Nalbuphine—Hypersensitivity—Tiotropium—chronic obstructive pulmonary disease	0.00292	0.003	CcSEcCtD
Nalbuphine—Hyperhidrosis—Salbutamol—chronic obstructive pulmonary disease	0.00292	0.003	CcSEcCtD
Nalbuphine—Dyspnoea—Formoterol—chronic obstructive pulmonary disease	0.00285	0.00293	CcSEcCtD
Nalbuphine—Dyspnoea—Arformoterol—chronic obstructive pulmonary disease	0.00285	0.00293	CcSEcCtD
Nalbuphine—Somnolence—Formoterol—chronic obstructive pulmonary disease	0.00284	0.00292	CcSEcCtD
Nalbuphine—Somnolence—Arformoterol—chronic obstructive pulmonary disease	0.00284	0.00292	CcSEcCtD
Nalbuphine—Hypotension—Salbutamol—chronic obstructive pulmonary disease	0.00282	0.0029	CcSEcCtD
Nalbuphine—Dyspepsia—Arformoterol—chronic obstructive pulmonary disease	0.00281	0.00289	CcSEcCtD
Nalbuphine—Dyspepsia—Formoterol—chronic obstructive pulmonary disease	0.00281	0.00289	CcSEcCtD
Nalbuphine—Paraesthesia—Montelukast—chronic obstructive pulmonary disease	0.00281	0.00289	CcSEcCtD
Nalbuphine—Pruritus—Tiotropium—chronic obstructive pulmonary disease	0.0028	0.00288	CcSEcCtD
Nalbuphine—Somnolence—Montelukast—chronic obstructive pulmonary disease	0.00278	0.00286	CcSEcCtD
Nalbuphine—Dizziness—Aminophylline—chronic obstructive pulmonary disease	0.00278	0.00285	CcSEcCtD
Nalbuphine—Dyspepsia—Montelukast—chronic obstructive pulmonary disease	0.00276	0.00283	CcSEcCtD
Nalbuphine—Paraesthesia—Salbutamol—chronic obstructive pulmonary disease	0.00271	0.00279	CcSEcCtD
Nalbuphine—Dyspnoea—Salbutamol—chronic obstructive pulmonary disease	0.00269	0.00277	CcSEcCtD
Nalbuphine—Somnolence—Salbutamol—chronic obstructive pulmonary disease	0.00268	0.00276	CcSEcCtD
Nalbuphine—Vomiting—Aminophylline—chronic obstructive pulmonary disease	0.00267	0.00274	CcSEcCtD
Nalbuphine—Dyspepsia—Salbutamol—chronic obstructive pulmonary disease	0.00266	0.00273	CcSEcCtD
Nalbuphine—Rash—Aminophylline—chronic obstructive pulmonary disease	0.00265	0.00272	CcSEcCtD
Nalbuphine—Dermatitis—Aminophylline—chronic obstructive pulmonary disease	0.00265	0.00272	CcSEcCtD
Nalbuphine—Feeling abnormal—Arformoterol—chronic obstructive pulmonary disease	0.00264	0.00271	CcSEcCtD
Nalbuphine—Feeling abnormal—Formoterol—chronic obstructive pulmonary disease	0.00264	0.00271	CcSEcCtD
Nalbuphine—Headache—Aminophylline—chronic obstructive pulmonary disease	0.00263	0.0027	CcSEcCtD
Nalbuphine—Dizziness—Tiotropium—chronic obstructive pulmonary disease	0.00262	0.00269	CcSEcCtD
Nalbuphine—Gastrointestinal pain—Formoterol—chronic obstructive pulmonary disease	0.00261	0.00269	CcSEcCtD
Nalbuphine—Gastrointestinal pain—Arformoterol—chronic obstructive pulmonary disease	0.00261	0.00269	CcSEcCtD
Nalbuphine—Gastrointestinal pain—Montelukast—chronic obstructive pulmonary disease	0.00256	0.00263	CcSEcCtD
Nalbuphine—Urticaria—Formoterol—chronic obstructive pulmonary disease	0.00254	0.00261	CcSEcCtD
Nalbuphine—Urticaria—Arformoterol—chronic obstructive pulmonary disease	0.00254	0.00261	CcSEcCtD
Nalbuphine—Body temperature increased—Formoterol—chronic obstructive pulmonary disease	0.00253	0.0026	CcSEcCtD
Nalbuphine—Abdominal pain—Arformoterol—chronic obstructive pulmonary disease	0.00253	0.0026	CcSEcCtD
Nalbuphine—Body temperature increased—Arformoterol—chronic obstructive pulmonary disease	0.00253	0.0026	CcSEcCtD
Nalbuphine—Abdominal pain—Formoterol—chronic obstructive pulmonary disease	0.00253	0.0026	CcSEcCtD
Nalbuphine—Vomiting—Tiotropium—chronic obstructive pulmonary disease	0.00252	0.00259	CcSEcCtD
Nalbuphine—Rash—Tiotropium—chronic obstructive pulmonary disease	0.0025	0.00257	CcSEcCtD
Nalbuphine—Dermatitis—Tiotropium—chronic obstructive pulmonary disease	0.0025	0.00256	CcSEcCtD
Nalbuphine—Nausea—Aminophylline—chronic obstructive pulmonary disease	0.0025	0.00256	CcSEcCtD
Nalbuphine—Urticaria—Montelukast—chronic obstructive pulmonary disease	0.00249	0.00256	CcSEcCtD
Nalbuphine—Feeling abnormal—Salbutamol—chronic obstructive pulmonary disease	0.00249	0.00256	CcSEcCtD
Nalbuphine—Naloxone—ALB—chronic obstructive pulmonary disease	0.00248	0.093	CrCbGaD
Nalbuphine—Headache—Tiotropium—chronic obstructive pulmonary disease	0.00248	0.00255	CcSEcCtD
Nalbuphine—Bradycardia—Prednisolone—chronic obstructive pulmonary disease	0.00248	0.00255	CcSEcCtD
Nalbuphine—Body temperature increased—Montelukast—chronic obstructive pulmonary disease	0.00248	0.00254	CcSEcCtD
Nalbuphine—Abdominal pain—Montelukast—chronic obstructive pulmonary disease	0.00248	0.00254	CcSEcCtD
Nalbuphine—Gastrointestinal pain—Salbutamol—chronic obstructive pulmonary disease	0.00247	0.00254	CcSEcCtD
Nalbuphine—Cardiac arrest—Prednisone—chronic obstructive pulmonary disease	0.00243	0.0025	CcSEcCtD
Nalbuphine—Urticaria—Salbutamol—chronic obstructive pulmonary disease	0.0024	0.00246	CcSEcCtD
Nalbuphine—Abdominal pain—Salbutamol—chronic obstructive pulmonary disease	0.00239	0.00245	CcSEcCtD
Nalbuphine—Body temperature increased—Salbutamol—chronic obstructive pulmonary disease	0.00239	0.00245	CcSEcCtD
Nalbuphine—Hypersensitivity—Formoterol—chronic obstructive pulmonary disease	0.00236	0.00242	CcSEcCtD
Nalbuphine—Hypersensitivity—Arformoterol—chronic obstructive pulmonary disease	0.00236	0.00242	CcSEcCtD
Nalbuphine—Nausea—Tiotropium—chronic obstructive pulmonary disease	0.00235	0.00242	CcSEcCtD
Nalbuphine—Hypersensitivity—Montelukast—chronic obstructive pulmonary disease	0.00231	0.00237	CcSEcCtD
Nalbuphine—Asthenia—Arformoterol—chronic obstructive pulmonary disease	0.00229	0.00236	CcSEcCtD
Nalbuphine—Asthenia—Formoterol—chronic obstructive pulmonary disease	0.00229	0.00236	CcSEcCtD
Nalbuphine—Pruritus—Formoterol—chronic obstructive pulmonary disease	0.00226	0.00232	CcSEcCtD
Nalbuphine—Pruritus—Arformoterol—chronic obstructive pulmonary disease	0.00226	0.00232	CcSEcCtD
Nalbuphine—Asthenia—Montelukast—chronic obstructive pulmonary disease	0.00225	0.00231	CcSEcCtD
Nalbuphine—Hypersensitivity—Salbutamol—chronic obstructive pulmonary disease	0.00222	0.00229	CcSEcCtD
Nalbuphine—Pruritus—Montelukast—chronic obstructive pulmonary disease	0.00222	0.00228	CcSEcCtD
Nalbuphine—Asthenia—Salbutamol—chronic obstructive pulmonary disease	0.00217	0.00223	CcSEcCtD
Nalbuphine—Sweating increased—Prednisone—chronic obstructive pulmonary disease	0.00216	0.00221	CcSEcCtD
Nalbuphine—Pruritus—Salbutamol—chronic obstructive pulmonary disease	0.00214	0.00219	CcSEcCtD
Nalbuphine—Erythema—Prednisolone—chronic obstructive pulmonary disease	0.00212	0.00218	CcSEcCtD
Nalbuphine—Dizziness—Arformoterol—chronic obstructive pulmonary disease	0.00211	0.00217	CcSEcCtD
Nalbuphine—Dizziness—Formoterol—chronic obstructive pulmonary disease	0.00211	0.00217	CcSEcCtD
Nalbuphine—Dizziness—Montelukast—chronic obstructive pulmonary disease	0.00207	0.00213	CcSEcCtD
Nalbuphine—Vomiting—Arformoterol—chronic obstructive pulmonary disease	0.00203	0.00209	CcSEcCtD
Nalbuphine—Vomiting—Formoterol—chronic obstructive pulmonary disease	0.00203	0.00209	CcSEcCtD
Nalbuphine—Rash—Formoterol—chronic obstructive pulmonary disease	0.00202	0.00207	CcSEcCtD
Nalbuphine—Rash—Arformoterol—chronic obstructive pulmonary disease	0.00202	0.00207	CcSEcCtD
Nalbuphine—Dermatitis—Formoterol—chronic obstructive pulmonary disease	0.00201	0.00207	CcSEcCtD
Nalbuphine—Dermatitis—Arformoterol—chronic obstructive pulmonary disease	0.00201	0.00207	CcSEcCtD
Nalbuphine—Headache—Formoterol—chronic obstructive pulmonary disease	0.002	0.00206	CcSEcCtD
Nalbuphine—Headache—Arformoterol—chronic obstructive pulmonary disease	0.002	0.00206	CcSEcCtD
Nalbuphine—Vision blurred—Prednisolone—chronic obstructive pulmonary disease	0.002	0.00205	CcSEcCtD
Nalbuphine—Dizziness—Salbutamol—chronic obstructive pulmonary disease	0.002	0.00205	CcSEcCtD
Nalbuphine—Vomiting—Montelukast—chronic obstructive pulmonary disease	0.00199	0.00205	CcSEcCtD
Nalbuphine—Rash—Montelukast—chronic obstructive pulmonary disease	0.00197	0.00203	CcSEcCtD
Nalbuphine—Dermatitis—Montelukast—chronic obstructive pulmonary disease	0.00197	0.00203	CcSEcCtD
Nalbuphine—Depression—Prednisone—chronic obstructive pulmonary disease	0.00197	0.00202	CcSEcCtD
Nalbuphine—Headache—Montelukast—chronic obstructive pulmonary disease	0.00196	0.00202	CcSEcCtD
Nalbuphine—Vomiting—Salbutamol—chronic obstructive pulmonary disease	0.00192	0.00197	CcSEcCtD
Nalbuphine—Vertigo—Prednisolone—chronic obstructive pulmonary disease	0.00191	0.00196	CcSEcCtD
Nalbuphine—Rash—Salbutamol—chronic obstructive pulmonary disease	0.0019	0.00196	CcSEcCtD
Nalbuphine—Syncope—Prednisolone—chronic obstructive pulmonary disease	0.0019	0.00196	CcSEcCtD
Nalbuphine—Dermatitis—Salbutamol—chronic obstructive pulmonary disease	0.0019	0.00195	CcSEcCtD
Nalbuphine—Nausea—Arformoterol—chronic obstructive pulmonary disease	0.0019	0.00195	CcSEcCtD
Nalbuphine—Nausea—Formoterol—chronic obstructive pulmonary disease	0.0019	0.00195	CcSEcCtD
Nalbuphine—Headache—Salbutamol—chronic obstructive pulmonary disease	0.00189	0.00194	CcSEcCtD
Nalbuphine—Loss of consciousness—Prednisolone—chronic obstructive pulmonary disease	0.00186	0.00192	CcSEcCtD
Nalbuphine—Nausea—Montelukast—chronic obstructive pulmonary disease	0.00186	0.00191	CcSEcCtD
Nalbuphine—Convulsion—Prednisolone—chronic obstructive pulmonary disease	0.00184	0.00189	CcSEcCtD
Nalbuphine—Hypertension—Prednisolone—chronic obstructive pulmonary disease	0.00183	0.00188	CcSEcCtD
Nalbuphine—Bradycardia—Prednisone—chronic obstructive pulmonary disease	0.0018	0.00185	CcSEcCtD
Nalbuphine—Nausea—Salbutamol—chronic obstructive pulmonary disease	0.00179	0.00184	CcSEcCtD
Nalbuphine—Hallucination—Prednisone—chronic obstructive pulmonary disease	0.00176	0.00181	CcSEcCtD
Nalbuphine—Oedema—Prednisolone—chronic obstructive pulmonary disease	0.00173	0.00178	CcSEcCtD
Nalbuphine—Shock—Prednisolone—chronic obstructive pulmonary disease	0.0017	0.00175	CcSEcCtD
Nalbuphine—Tachycardia—Prednisolone—chronic obstructive pulmonary disease	0.00169	0.00174	CcSEcCtD
Nalbuphine—Hyperhidrosis—Prednisolone—chronic obstructive pulmonary disease	0.00167	0.00172	CcSEcCtD
Nalbuphine—Flushing—Prednisone—chronic obstructive pulmonary disease	0.00164	0.00169	CcSEcCtD
Nalbuphine—Paraesthesia—Prednisolone—chronic obstructive pulmonary disease	0.00156	0.0016	CcSEcCtD
Nalbuphine—Erythema—Prednisone—chronic obstructive pulmonary disease	0.00154	0.00158	CcSEcCtD
Nalbuphine—Vision blurred—Prednisone—chronic obstructive pulmonary disease	0.00145	0.00149	CcSEcCtD
Nalbuphine—Feeling abnormal—Prednisolone—chronic obstructive pulmonary disease	0.00143	0.00147	CcSEcCtD
Nalbuphine—Agitation—Prednisone—chronic obstructive pulmonary disease	0.00142	0.00146	CcSEcCtD
Nalbuphine—Vertigo—Prednisone—chronic obstructive pulmonary disease	0.00139	0.00142	CcSEcCtD
Nalbuphine—Syncope—Prednisone—chronic obstructive pulmonary disease	0.00138	0.00142	CcSEcCtD
Nalbuphine—Urticaria—Prednisolone—chronic obstructive pulmonary disease	0.00138	0.00141	CcSEcCtD
Nalbuphine—Loss of consciousness—Prednisone—chronic obstructive pulmonary disease	0.00136	0.00139	CcSEcCtD
Nalbuphine—Convulsion—Prednisone—chronic obstructive pulmonary disease	0.00134	0.00137	CcSEcCtD
Nalbuphine—Hypertension—Prednisone—chronic obstructive pulmonary disease	0.00133	0.00137	CcSEcCtD
Nalbuphine—Anxiety—Prednisone—chronic obstructive pulmonary disease	0.00131	0.00134	CcSEcCtD
Nalbuphine—Hypersensitivity—Prednisolone—chronic obstructive pulmonary disease	0.00128	0.00131	CcSEcCtD
Nalbuphine—Oedema—Prednisone—chronic obstructive pulmonary disease	0.00126	0.00129	CcSEcCtD
Nalbuphine—Shock—Prednisone—chronic obstructive pulmonary disease	0.00124	0.00127	CcSEcCtD
Nalbuphine—Tachycardia—Prednisone—chronic obstructive pulmonary disease	0.00123	0.00126	CcSEcCtD
Nalbuphine—Hyperhidrosis—Prednisone—chronic obstructive pulmonary disease	0.00122	0.00125	CcSEcCtD
Nalbuphine—Dizziness—Prednisolone—chronic obstructive pulmonary disease	0.00115	0.00118	CcSEcCtD
Nalbuphine—Paraesthesia—Prednisone—chronic obstructive pulmonary disease	0.00113	0.00116	CcSEcCtD
Nalbuphine—Dyspepsia—Prednisone—chronic obstructive pulmonary disease	0.00111	0.00114	CcSEcCtD
Nalbuphine—Rash—Prednisolone—chronic obstructive pulmonary disease	0.00109	0.00112	CcSEcCtD
Nalbuphine—Dermatitis—Prednisolone—chronic obstructive pulmonary disease	0.00109	0.00112	CcSEcCtD
Nalbuphine—Headache—Prednisolone—chronic obstructive pulmonary disease	0.00108	0.00111	CcSEcCtD
Nalbuphine—Feeling abnormal—Prednisone—chronic obstructive pulmonary disease	0.00104	0.00107	CcSEcCtD
Nalbuphine—Gastrointestinal pain—Prednisone—chronic obstructive pulmonary disease	0.00103	0.00106	CcSEcCtD
Nalbuphine—Nausea—Prednisolone—chronic obstructive pulmonary disease	0.00103	0.00106	CcSEcCtD
Nalbuphine—Urticaria—Prednisone—chronic obstructive pulmonary disease	0.001	0.00103	CcSEcCtD
Nalbuphine—Abdominal pain—Prednisone—chronic obstructive pulmonary disease	0.000995	0.00102	CcSEcCtD
Nalbuphine—Body temperature increased—Prednisone—chronic obstructive pulmonary disease	0.000995	0.00102	CcSEcCtD
Nalbuphine—Hypersensitivity—Prednisone—chronic obstructive pulmonary disease	0.000927	0.000953	CcSEcCtD
Nalbuphine—Asthenia—Prednisone—chronic obstructive pulmonary disease	0.000903	0.000928	CcSEcCtD
Nalbuphine—Pruritus—Prednisone—chronic obstructive pulmonary disease	0.00089	0.000915	CcSEcCtD
Nalbuphine—Dizziness—Prednisone—chronic obstructive pulmonary disease	0.000832	0.000855	CcSEcCtD
Nalbuphine—Vomiting—Prednisone—chronic obstructive pulmonary disease	0.0008	0.000822	CcSEcCtD
Nalbuphine—Rash—Prednisone—chronic obstructive pulmonary disease	0.000793	0.000815	CcSEcCtD
Nalbuphine—Dermatitis—Prednisone—chronic obstructive pulmonary disease	0.000793	0.000814	CcSEcCtD
Nalbuphine—Headache—Prednisone—chronic obstructive pulmonary disease	0.000788	0.00081	CcSEcCtD
Nalbuphine—Nausea—Prednisone—chronic obstructive pulmonary disease	0.000747	0.000768	CcSEcCtD
